Gal Aviel, Bruria Hirsh-Raccah, Islam Idais, Rafat Abu Ghannam, Maxim Komodei, Alexander Lipey-Dyamant, Ori Wald, Amit Korach
{"title":"二尖瓣手术后三尖瓣返流恶化:荟萃分析和荟萃回归。","authors":"Gal Aviel, Bruria Hirsh-Raccah, Islam Idais, Rafat Abu Ghannam, Maxim Komodei, Alexander Lipey-Dyamant, Ori Wald, Amit Korach","doi":"10.1016/j.ijcard.2025.133931","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Reports of tricuspid valve regurgitation (TR) following mitral valve (MV) surgery are unclear. This study aims to estimate the prevalence of worsening TR (WTR) following MV surgery for non-rheumatic mitral regurgitation and the benefit of concomitant tricuspid annuloplasty.</p><p><strong>Methods: </strong>Electronic databases including Embase, PubMed, GoogleScholar, and Cochrane Library were searched between 2013 and 2024. A systematic review of the literature was conducted to include cohort studies, case-control studies and randomized-controlled trials. WTR was defined as ≥ moderate TR or an increase in TR severity of ≥2 grades on follow-up echocardiography. A random effects meta-analysis was performed. Subgroup analysis was conducted to estimate the benefit of a concomitant TV annuloplasty. A meta-regression was conducted to identify potential variables accounting for between-study heterogeneity. Sensitivity analyses were used to confirm the robustness of the reported results.</p><p><strong>Results: </strong>Of 8923 studies identified, 8 studies were included in the final analysis involving 2978 patients and 14,592 patient years (MV surgery-only group = 1991 patients, TV annuloplasty group = 987). WTR occurred in 9 % (95 %CI:4-22) of patients after MV surgery over a pooled follow-up of 4.9 [3.1-6.7] years. A concomitant TV annuloplasty resulted in a significant reduction in the prevalence of WTR (OR = 0.27, 95 %CI: 0.13-0.57, p = 0.0079). A trend for lower overall mortality was detected in the TV annuloplasty group (OR = 0.73, 95 %CI: 0.5-1.08). The pooled estimates were not significantly affected using a leave-one-out analysis meta-analysis.</p><p><strong>Conclusions: </strong>Despite surgical treatment of non-rheumatic mitral regurgitation, TR progresses in a considerable number of patients. Concomitant tricuspid annuloplasty significantly decreases the prevalence of WTR without affecting mortality.</p>","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":" ","pages":"133931"},"PeriodicalIF":3.2000,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Worsening tricuspid regurgitation after mitral valve surgery: a meta-analysis and meta-regression.\",\"authors\":\"Gal Aviel, Bruria Hirsh-Raccah, Islam Idais, Rafat Abu Ghannam, Maxim Komodei, Alexander Lipey-Dyamant, Ori Wald, Amit Korach\",\"doi\":\"10.1016/j.ijcard.2025.133931\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Reports of tricuspid valve regurgitation (TR) following mitral valve (MV) surgery are unclear. This study aims to estimate the prevalence of worsening TR (WTR) following MV surgery for non-rheumatic mitral regurgitation and the benefit of concomitant tricuspid annuloplasty.</p><p><strong>Methods: </strong>Electronic databases including Embase, PubMed, GoogleScholar, and Cochrane Library were searched between 2013 and 2024. A systematic review of the literature was conducted to include cohort studies, case-control studies and randomized-controlled trials. WTR was defined as ≥ moderate TR or an increase in TR severity of ≥2 grades on follow-up echocardiography. A random effects meta-analysis was performed. Subgroup analysis was conducted to estimate the benefit of a concomitant TV annuloplasty. A meta-regression was conducted to identify potential variables accounting for between-study heterogeneity. Sensitivity analyses were used to confirm the robustness of the reported results.</p><p><strong>Results: </strong>Of 8923 studies identified, 8 studies were included in the final analysis involving 2978 patients and 14,592 patient years (MV surgery-only group = 1991 patients, TV annuloplasty group = 987). WTR occurred in 9 % (95 %CI:4-22) of patients after MV surgery over a pooled follow-up of 4.9 [3.1-6.7] years. A concomitant TV annuloplasty resulted in a significant reduction in the prevalence of WTR (OR = 0.27, 95 %CI: 0.13-0.57, p = 0.0079). A trend for lower overall mortality was detected in the TV annuloplasty group (OR = 0.73, 95 %CI: 0.5-1.08). The pooled estimates were not significantly affected using a leave-one-out analysis meta-analysis.</p><p><strong>Conclusions: </strong>Despite surgical treatment of non-rheumatic mitral regurgitation, TR progresses in a considerable number of patients. Concomitant tricuspid annuloplasty significantly decreases the prevalence of WTR without affecting mortality.</p>\",\"PeriodicalId\":13710,\"journal\":{\"name\":\"International journal of cardiology\",\"volume\":\" \",\"pages\":\"133931\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-10-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ijcard.2025.133931\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijcard.2025.133931","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Worsening tricuspid regurgitation after mitral valve surgery: a meta-analysis and meta-regression.
Objectives: Reports of tricuspid valve regurgitation (TR) following mitral valve (MV) surgery are unclear. This study aims to estimate the prevalence of worsening TR (WTR) following MV surgery for non-rheumatic mitral regurgitation and the benefit of concomitant tricuspid annuloplasty.
Methods: Electronic databases including Embase, PubMed, GoogleScholar, and Cochrane Library were searched between 2013 and 2024. A systematic review of the literature was conducted to include cohort studies, case-control studies and randomized-controlled trials. WTR was defined as ≥ moderate TR or an increase in TR severity of ≥2 grades on follow-up echocardiography. A random effects meta-analysis was performed. Subgroup analysis was conducted to estimate the benefit of a concomitant TV annuloplasty. A meta-regression was conducted to identify potential variables accounting for between-study heterogeneity. Sensitivity analyses were used to confirm the robustness of the reported results.
Results: Of 8923 studies identified, 8 studies were included in the final analysis involving 2978 patients and 14,592 patient years (MV surgery-only group = 1991 patients, TV annuloplasty group = 987). WTR occurred in 9 % (95 %CI:4-22) of patients after MV surgery over a pooled follow-up of 4.9 [3.1-6.7] years. A concomitant TV annuloplasty resulted in a significant reduction in the prevalence of WTR (OR = 0.27, 95 %CI: 0.13-0.57, p = 0.0079). A trend for lower overall mortality was detected in the TV annuloplasty group (OR = 0.73, 95 %CI: 0.5-1.08). The pooled estimates were not significantly affected using a leave-one-out analysis meta-analysis.
Conclusions: Despite surgical treatment of non-rheumatic mitral regurgitation, TR progresses in a considerable number of patients. Concomitant tricuspid annuloplasty significantly decreases the prevalence of WTR without affecting mortality.
期刊介绍:
The International Journal of Cardiology is devoted to cardiology in the broadest sense. Both basic research and clinical papers can be submitted. The journal serves the interest of both practicing clinicians and researchers.
In addition to original papers, we are launching a range of new manuscript types, including Consensus and Position Papers, Systematic Reviews, Meta-analyses, and Short communications. Case reports are no longer acceptable. Controversial techniques, issues on health policy and social medicine are discussed and serve as useful tools for encouraging debate.